Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials (English, HTML)
Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials: English HTML file. From Health Canada, updated Dec 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-12-02
Health Canada’s Therapeutic Products Directorate (TPD) and Biologics and Genetic Therapies Directorate (BGTD) are responsible for reviewing the applications for authorization to sell or import drugs for the purposes of conducting clinical trials in Canada.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file